Login / Signup

Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study.

Ching-Lung CheungChor-Wing SingWallis C Y LauGloria H Y LiGregory Y H LipKathryn C B TanBernard M Y CheungEsther W Y ChanIan C K Wong
Published in: Cardiovascular diabetology (2021)
Among adults with AF receiving OACs, the use of dabigatran had the lowest risk of diabetes when compared with warfarin use.
Keyphrases
  • direct oral anticoagulants
  • atrial fibrillation
  • venous thromboembolism
  • cardiovascular disease
  • type diabetes
  • oral anticoagulants
  • glycemic control
  • metabolic syndrome
  • insulin resistance